Medical Polyoxymethylene Market - By Type, By Application, By End-User & Forecast, 2024 – 2032

Medical Polyoxymethylene Market Size

The global medical polyoxymethylene market was valued at around USD 118.4 million in 2023 and is expected to register a CAGR of over 6.3% between 2024 and 2032.
 

Homopolymer polyoxymethylene is widely used in the medical market due to its superior mechanical properties, including higher stiffness, strength, and crystallinity compared to copolymer variants. These attributes make it ideal for precision medical components like surgical instrument handles, catheter parts, and other medical devices requiring dimensional stability and rigidity. Additionally, its resistance to chemicals, low friction, and excellent wear properties make it suitable for applications that undergo repeated sterilization and use.
 

A general trend in the global market shows increasing demand for high-performance materials that ensure safety, longevity, and efficiency in medical devices. As the healthcare industry evolves with technological advancements and more stringent regulations, the need for reliable materials like homopolymer POM continues to grow. This demand, combined with the expanding medical device sector, is driving the adoption of homopolymer POM, significantly influencing the market's future trajectory.
 

In 2023, the global pharmaceutical market was valued at approximately USD 1.6 trillion, reflecting the immense growth and innovation within the healthcare sector. This expansion directly influences the demand for materials like medical polyoxymethylene (POM), widely used in pharmaceutical devices such as insulin pens, inhalers, and surgical tools. As the pharmaceutical industry continues to grow, the adoption of POM for high-precision and durable medical components is expected to rise, contributing to the development of advanced healthcare solutions.
 

High production and material costs are significant factors restraining the growth of the medical polyoxymethylene (POM) market. The specialized grades of POM required for medical applications must meet stringent safety and regulatory standards, leading to higher manufacturing expenses. Additionally, the raw materials used in producing medical-grade POM are more expensive due to their high purity requirements, further driving up costs. Advanced manufacturing processes, along with the need for sterilization resistance and biocompatibility, add to the complexity and expense of producing medical POM components. These increased costs can hinder the widespread adoption of POM in cost-sensitive healthcare environments, making it a notable restraint in the market.
 

Medical Polyoxymethylene Market Trends

The growing demand for medical devices is a key driver in the medical polyoxymethylene (POM) market. With the increasing prevalence of chronic diseases, aging populations, and advancements in healthcare technologies, the need for high-performance, durable medical devices is on the rise. POM is widely used in the manufacturing of components for devices like inhalers, insulin pens, dialysis machines, and surgical instruments due to its excellent mechanical properties, low friction, and chemical resistance. The global shift towards minimally invasive surgeries and home healthcare devices further fuels the demand for POM, as it meets the requirements for precision and reliability in medical components. This surge in medical device production directly influences the growth of the medical POM market, making it a significant driver for market expansion.
 

Increased healthcare spending globally is a crucial driver in the medical polyoxymethylene market. Governments and private sectors across the world are significantly investing in healthcare infrastructure, technological advancements, and patient care services, especially in response to rising chronic diseases and an aging population. This financial boost accelerates the development and adoption of advanced medical devices that rely on durable, biocompatible materials like POM.
 

The expansion of healthcare facilities, especially in developing regions, is creating a larger demand for medical equipment such as surgical instruments, drug delivery devices, and diagnostic tools, all of which utilize POM for its superior mechanical properties, chemical resistance, and sterilization capabilities. As healthcare spending grows, so does the need for high-performance materials in critical medical devices, driving the demand for medical-grade polyoxymethylene and contributing to the market's growth.
 

Medical Polyoxymethylene Market Analysis

Based on type, the market is divided into homopolymer and copolymer. Homopolymer held the dominant market value of USD 69.2 million in 2023 and expected to reach USD 119.4 million by 2032. Homopolymer dominates the medical polyoxymethylene industry due to its superior mechanical properties, such as higher stiffness, strength, and crystallinity, which make it ideal for precision medical devices. Its excellent dimensional stability and low friction are essential for applications like surgical instruments, insulin pens, and inhalers. Homopolymer also provides better resistance to wear and chemical exposure, making it suitable for repeated sterilization processes in medical environments. These performance advantages make homopolymer the preferred choice over copolymer in many medical applications, leading to its dominance in the market.
 

Based on application, the market is categorized into dialysis machine, handles for surgical instruments, inhalers, insulin pen, medical trays and others. Dialysis machine accounted for 30% market share in 2023 and is projected to grow significantly till 2032. Dialysis machines dominate the medical polyoxymethylene (POM) market due to the critical need for durable, biocompatible components in their construction. POM’s superior mechanical strength, chemical resistance, and low friction properties make it ideal for parts like pumps, valves, and connectors used in dialysis equipment. Additionally, the frequent use and sterilization requirements of dialysis machines demand materials that maintain performance and integrity over time, a key strength of POM. With the rising prevalence of kidney-related diseases globally, the demand for dialysis machines continues to grow, reinforcing their dominance in the medical POM market.
 

Based on end-user, the market is categorized into medical device, hospitals & clinics, pharmaceutical, research laboratories and others. Medical device accounted for 39% market share in 2023 and is projected to grow significantly up to 2032. Medical devices dominate the medical polyoxymethylene (POM) market due to the material's excellent strength, low friction, and chemical resistance, which are essential for precision and durability in devices like inhalers, insulin pens, and surgical tools. POM's ability to withstand repeated sterilization and provide high performance in critical medical applications makes it a preferred material. The expanding global demand for advanced medical devices further drives POM's dominance in this segment.
 

North America dominated the global medical polyoxymethylene market in 2023. It generated a revenue of USD 39.4 million in 2023.  North America dominates the medical polyoxymethylene (POM) market due to its well-established healthcare infrastructure, advanced medical technology, and significant investment in healthcare research and development. The region’s focus on producing high-quality, innovative medical devices drives the demand for POM, which is known for its durability, chemical resistance, and precision in medical applications. Additionally, the rising prevalence of chronic diseases and the aging population in North America further fuel the demand for medical devices, leading to a strong market for medical-grade POM materials.
 

The United States leads the market within North America, driven by its large-scale medical device manufacturing sector and robust healthcare spending. The U.S. has stringent regulations ensuring the use of biocompatible materials, further boosting the demand for medical POM. Canada follows with a growing medical device industry and increasing healthcare investments, contributing to the region’s overall dominance in the global medical POM market.
 

Medical Polyoxymethylene Market Share

ASAHI KASEI CORPORATION, BASF SE, Celanese Corporation, Delrin USA, LLC and Ensinger collectively dominate the medical polyoxymethylene industry with their extensive industry experience, innovative product offerings, and widespread global presence.
 

Asahi Kasei Corporation is a global leader in chemical and material production, with a strong focus on healthcare solutions. The company offers high-performance polymers, including polyoxymethylene (POM), which is widely used in medical device components due to its mechanical strength and durability. Asahi Kasei’s expertise in producing advanced medical materials positions it as a key player in the global market. BASF SE is one of the largest chemical producers in the world, known for its extensive portfolio of engineering plastics, including POM. BASF’s medical-grade polyoxymethylene is utilized in various healthcare applications, such as insulin pens and inhalers, for its excellent chemical resistance and biocompatibility. The company’s innovations in healthcare materials contribute significantly to the growth of the medical POM market.
 

Celanese Corporation is a leading manufacturer of specialty materials and chemicals, including its renowned polyoxymethylene product line. Celanese’s POM is highly valued in the medical industry for its dimensional stability and resistance to wear, making it ideal for precision devices like surgical instruments and drug delivery systems. Its strong focus on healthcare applications makes it a key player in the medical POM market. Delrin USA, LLC, a subsidiary of DuPont, specializes in producing Delrin, a high-performance acetal resin widely used in the medical field. Delrin POM is preferred for medical devices due to its strength, low friction, and ease of machining, making it suitable for components in dialysis machines, inhalers, and other precision medical instruments. Delrin’s contributions are essential to the medical polyoxymethylene market. Ensinger is a global manufacturer of high-performance plastics, including medical-grade POM, designed to meet stringent healthcare standards. Ensinger’s polyoxymethylene is commonly used in surgical instrument handles, medical trays, and diagnostic equipment, where durability and sterilization resistance are crucial. The company’s focus on innovation and material quality positions it strongly in the medical POM market.
 

These market leaders collectively shape the competitive landscape of the Medical polyoxymethylene industry, driving innovation, setting industry standards, and meeting the evolving demands of customers worldwide. With their focus on research and development, technological advancements, and strategic partnerships, these companies continue to expand their market share and strengthen their foothold in key regions. Their relentless pursuit of excellence, coupled with their customer-centric approach, positions them as preferred suppliers of Medical polyoxymethylene, contributing significantly to the growth and development of the global construction industry.
 

Medical Polyoxymethylene Market Companies

Major players operating in the medical polyoxymethylene industry include:

• ASAHI KASEI CORPORATION
• BASF SE
• Celanese Corporation
• Delrin USA, LLC
• Ensinger
• GLOBAL POLYACETAL CO., LTD.
• Kolon ENP
• Mitsubishi Chemical Corporation
• Polyplastics Co., Ltd.
• SABIC
   

Medical Polyoxymethylene Industry News

• In May 2024, Celanese Corporation announced the conversion of its POM-making process into a sustainable practice. The company aims to ensure that its production facility in Bishop, Texas in the U.S. achieves a net zero carbon footprint through these initiatives.
   
• In June 2023, BASF SE announced changes in its direct business for the Ultraform in Europe. As per these changes, the company announced the transfer of its POM sales process to its long-standing partners Ultrapolymers Group and ALBIS.
   

The medical polyoxymethylene market research report includes in-depth coverage of the industry, with estimates & forecast in terms of revenue and volume (USD Million) (Kilo Tons) from 2021 to 2032, for the following segments:

Click here to Buy Section of this Report

Market, By Type

• Homopolymer
• Copolymer

Market, By Application

• Dialysis machine
• Handles for surgical instruments
• Inhalers
• Insulin pen
• Medical trays
• Others

Market, By End-User

• Medical device
• Hospitals & clinics
• Pharmaceutical
• Research laboratories
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada 
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• MEA
  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of MEA